Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ingmar Waardenburg"'
Autor:
M. Yldau van der Ende, Luis Eduardo Juarez‐Orozco, Ingmar Waardenburg, Erik Lipsic, Remco A. J. Schurer, Hindrik W. van der Werf, Emelia J. Benjamin, Dirk Jan van Veldhuisen, Harold Snieder, Pim van der Harst
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 13 (2020)
Background Myocardial infarction is an important cause of morbidity and mortality in both men and women. Atypical or the absence of symptoms, more prevalent among women, may contribute to unrecognized myocardial infarctions and missed opportunities f
Externí odkaz:
https://doaj.org/article/dea8f7e29cb642c98ac480c0a1829d64
Autor:
Robert van Barneveld, Vincent E. Hagens, Wybe Nieuwland, E Lipsic, Pim van der Harst, Edward Jorna, Louis Bartels, Carien van Well, Peter van der Meer, Thea van Asselt, YJ Gu, Dennis Sagel, Luis Juarez Orozco, Ryanne Addink, Roelof Lettinga, Antoon Oomen, Derk Drenth, Radboud van Roosmalen, Ingmar Waardenburg, Sjoerd Hofma, Roelof Kijlstra, Pieter J. Vlaar, Rutger L. Anthonio
Publikováno v:
Emergency medicine journal, 38, 814-819. BMJ PUBLISHING GROUP
Emergency Medicine Journal : EMJ
Emergency Medicine Journal : EMJ
ObjectivesThe History, ECG, Age, Risk Factors and Troponin (HEART) Score is a decision support tool applied by physicians in the emergency department developed to risk stratify low-risk patients presenting with chest pain. We assessed the potential v
Autor:
Harold Snieder, Jens H. J. Bos, E Lipsic, M. Yldau van der Ende, Pim van der Harst, Eelko Hak, Ingmar Waardenburg
Publikováno v:
International Journal of Cardiology: Hypertension, 6:100042
International Journal of Cardiology. Hypertension, Vol 6, Iss, Pp 100042-(2020)
International Journal of Cardiology Hypertension
International Journal of Cardiology. Hypertension, Vol 6, Iss, Pp 100042-(2020)
International Journal of Cardiology Hypertension
Background It is unknown whether population based single assessment of cardiovascular disease (CVD) risk and feedback to individuals and general practitioners results in initiation of preventive cardiovascular pharmacotherapy in those at risk. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9385196f133ec11d2ff8aa769a5c45
https://research.rug.nl/en/publications/acaa8a88-1b1e-49c2-8c1a-9d99e4bfecab
https://research.rug.nl/en/publications/acaa8a88-1b1e-49c2-8c1a-9d99e4bfecab
Autor:
Luis Eduardo Juarez-Orozco, Remco A. J. Schurer, Emelia J. Benjamin, M. Yldau van der Ende, Dirk J. van Veldhuisen, Erik Lipsic, Hindrik W. van der Werf, Harold Snieder, Ingmar Waardenburg, Pim van der Harst
Publikováno v:
Journal of the American Heart Association, 9(13):015519. Wiley
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Myocardial infarction is an important cause of morbidity and mortality in both men and women. Atypical or the absence of symptoms, more prevalent among women, may contribute to unrecognized myocardial infarctions and missed opportunities f